Related Experiment Videos
Oxpentifylline in Parkinson's disease
Journal of Neurology, Neurosurgery, and Psychiatry
|April 1, 1980
Abstract:
The effects of oxpentifylline were assessed in a double-blind trial in 11 patients with Parkinson's disease already under treatment. No significant improvement was noted. Eight patients developed involuntary movements or a worsening of movements if already present. The significance of this unexpected finding is discussed.
Insights
Oxpentyfylline did not improve Parkinson's disease symptoms in a small trial. Unexpectedly, most patients experienced worsening or new involuntary movements, suggesting potential adverse effects.
Area of Science:
- Neurology
- Pharmacology
Background:
- Parkinson's disease is a neurodegenerative disorder affecting motor control.
- Current treatments aim to manage symptoms but do not halt disease progression.
Purpose of the Study:
- To evaluate the efficacy of oxpentifylline in patients with Parkinson's disease.
- To assess the safety and tolerability of oxpentifylline in this patient population.
Main Methods:
- A double-blind, placebo-controlled trial was conducted.
- Eleven patients with Parkinson's disease, already on treatment, participated.
- Oxpentyfylline was administered to assess its effects.
Main Results:
- No significant improvement in Parkinson's disease symptoms was observed.
- Eight out of eleven patients experienced new or worsened involuntary movements.
- This finding suggests a potential adverse effect of oxpentifylline on motor function.
Conclusions:
- Oxpentyfylline demonstrated no therapeutic benefit for Parkinson's disease symptoms.
- The drug may exacerbate or induce motor complications in Parkinson's patients.
- Further research is warranted to understand the implications of these adverse motor effects.